1) an identifiable patient; 2) an identifiable reporter; 3) a specific drug; and 4) an adverse event.
Since many posters use Web pseudonyms, this would probably knock out most messages, but what's the expectation on the pharma company to track down the reporter's real identity?
Would you like to comment?
Join Diigo for a free account, or sign in if you are already a member.
Would you like to comment?
Join Diigo for a free account, or sign in if you are already a member.